
Jim Cramer Praises Elanco Animal Health: 'They've Turned That Company Around'

I'm PortAI, I can summarize articles.
Jim Cramer praised Elanco Animal Health on CNBC's 'Mad Money,' recommending buying its stock due to the company's turnaround. Barclays analyst Glen Santangelo initiated coverage with an Overweight rating and a $30 price target. Cramer also discussed Rocket Lab, Lithium Americas, Daktronics, M&T Bank, and Ondas Holdings, providing various recommendations. Elanco shares fell 1.8%, Rocket Lab shares declined 2.8%, Lithium Americas shares fell 3.6%, Daktronics shares declined 0.9%, M&T Bank shares rose 1%, and Ondas Holdings shares dipped 6.1%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

